GCIA
DMIIR

Gabelli & Co Investment Advisers’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
179,500
– – ﹤0.01% 298
2026
Q1 		$14.4K Buy
+179,500
New +$20.4K ﹤0.01% 280

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Gabelli & Co Investment Advisers's DMIIR Position: Q2 2026 in Review

Gabelli & Co Investment Advisers held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q2 2026 at 179,500 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

Gabelli & Co Investment Advisers first reported a position in DMIIR in Q1 2026 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

  • Gabelli & Co Investment Advisers held 179,500 shares of Drugs Made In America Acquisition II Corp Right worth $14.4K as of Q2 2026.
  • Gabelli & Co Investment Advisers left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #298 holding.
  • Gabelli & Co Investment Advisers first reported a position in Drugs Made In America Acquisition II Corp Right in Q1 2026 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.